Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06006884 · ClinicalTrials.gov registry record

A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

A clinical trial of COVID-19, sponsored by Mayo Clinic.

Recruiting
Registry status
75
Enrollment target
1
Study location

NCT06006884 is a study of COVID-19 that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 75 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06006884, a study of COVID-19, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection

Conditions Studied

Interventions

  • PROCEDURE Bronchoscopies and Bronchoalveolar Lavages (BALs)
  • DIAGNOSTIC_TEST Chest Tomography (CT)
  • DIAGNOSTIC_TEST Electrocardiogram (ECG)
  • DIAGNOSTIC_TEST Pulmonary function tests (PFTs)
  • DIAGNOSTIC_TEST 6 minute walk test (6MWT)

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-01-10
Est. Completion 2027-08

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06006884

The ClinicalTrials.gov registry entry for NCT06006884 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 5 interventions - of which Bronchoscopies and Bronchoalveolar Lavages (BALs) is the first listed.

NCT06006884 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06006884 about?

NCT06006884 is a clinical study titled "A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae". The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection

What is the current status of trial NCT06006884?

This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-01-10. Estimated completion is 2027-08.

What conditions does trial NCT06006884 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT06006884?

The interventions under investigation include: Bronchoscopies and Bronchoalveolar Lavages (BALs) (PROCEDURE), Chest Tomography (CT) (DIAGNOSTIC_TEST), Electrocardiogram (ECG) (DIAGNOSTIC_TEST), Pulmonary function tests (PFTs) (DIAGNOSTIC_TEST), 6 minute walk test (6MWT) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06006884?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06006884 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.